Related Experiment Video
Updated: Jan 5, 2026
09:48
In vitro Quantitative Imaging Assay for Phagocytosis of Dead Neuroblastoma Cells by iPSC-Macrophages
Published on: February 14, 2021
6.2K
Death by microglia.
Shahrnaz Kemal1, Robert Vassar2
1Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL.
The Journal of Experimental Medicine
|October 25, 2019
Summary
Microglia and apolipoprotein E (ApoE) drive neurodegeneration in tauopathies like Alzheimer's disease. Their collaboration in innate immunity accelerates disease progression, as shown in a mouse model.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- The roles of microglia and apolipoprotein E (ApoE) in tauopathies, including Alzheimer's disease, are not fully understood.
- Microglia are the primary immune cells of the brain, and ApoE is a key lipid-binding protein implicated in neurodegenerative diseases.
Purpose of the Study:
- To investigate the collaborative roles of microglia and ApoE in the pathogenesis of tauopathy.
- To elucidate the mechanisms by which microglia-mediated immunity and ApoE influence neurodegeneration and disease progression.
Main Methods:
- Utilized a mouse model of tauopathy.
- Investigated the interplay between microglia activation, ApoE expression, and neurodegenerative markers.
- Assessed the impact on disease progression and cognitive deficits.
Main Results:
- Demonstrated that microglia-mediated innate immunity collaborates with ApoE to exacerbate neurodegeneration.
- Showed that this collaboration accelerates disease progression in the studied mouse model.
- Identified specific immune pathways involving microglia and ApoE that contribute to tauopathy.
Conclusions:
- Microglia and ApoE are critical players in driving neurodegeneration in tauopathies.
- Targeting the interaction between microglia-mediated immunity and ApoE may offer therapeutic strategies for Alzheimer's disease and related tauopathies.
Related Concept Videos
01:30Overview of Cell Death
9.2K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.2K
01:16Necrosis
6.2K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.2K
01:18Autophagic Cell Death
4.3K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.3K